Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer

NCT01142102 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Trans Tasman Radiation Oncology Group